Metabolic Syndrome Criteria and the Effect of Testosterone Treatment in Young Men With Hypogonadism

Phase 4 Study of About the Effect of Testosterone Treatment on the Components of Metabolic Syndrome

Status

Completed

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01160341

Enrollment

312

Registered

2010-07-12

Start date

2009-08-31

Completion date

2010-01-31

Last updated

2010-07-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypogonadism

Keywords

Metabolic syndrome, Hypogonadism, Testosterone

Brief summary

The study is designed to answer the following questions: 1. Is hypogonadism a cause for the metabolic syndrome ? 2. What is the effect of testosterone replacement on the metabolic parameters ?

Detailed description

This is a retrospective design, which is performed by investigating the registrations of patients with hypogonadotrophic hypogonadism between the years 2002-2009.

Interventions

DRUGTestosteron

Testosteron 250mg injection per 3-4 weeks for 6 months

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

SCREENING

Masking

NONE

Eligibility

Sex/Gender

MALE

Age

18 Years to 26 Years

Healthy volunteers

Yes

Inclusion criteria

* Men * Congenital hypogonadism * Treatment Naive

Exclusion criteria

* Previous history of androgen replacement * Hypertension * Diabetes mellitus

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026